Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424485

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424485

Global Bio-imaging Market, By Imaging Modality (Magnetic Resonance Imaging, Computed Tomography, Position Emission Tomography, Ultrasound, X-ray, Others), By End User, By Geography

PUBLISHED:
PAGES: 172 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Global bio-imaging market size is expected to reach US$ 15.58 Bn by 2030, from US$ 5.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 15.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 5.74 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 15.30% 2030/2031 Value Projection: US$ 15.58 Bn
Figure 1. Global Bio-imaging Market Share (%), By Region, 2023
Global Bio-imaging Market - IMG1

Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.

Market Dynamics:

Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.

Key features of the study:

  • This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market

Detailed Segmentation:

  • Global Bio-imaging Market Segmentation, By Imaging Modality:
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Position Emission Tomography (PET)
    • Ultrasound
    • X-ray
    • Others
  • Global Bio-imaging Market Segmentation, By End User:
    • Hospitals & diagnostic centers
    • Academic & research institutes
    • Pharmaceutical & biotech companies
    • Others
  • Global Bio-imaging Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Bio-imaging Market:
    • Bracco Imaging S.P.A
    • Bayer HealthCare Pharmaceuticals
    • Esaote S.p.A
    • Digirad Corporation
    • FONAR Corporation
    • GE Healthcare
    • Hologic Inc
    • Hitachi Medical Corporation
    • Lantheus Medical Imaging, Inc.
    • Covidien Pharmaceuticals
    • Mindray Medical International Limited.
    • Gamma Medica Inc
    • Samsung Medison Co., Ltd.
    • Philips Healthcare
Product Code: CMI6581

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Bio-imaging, By Imaging Modality
    • Market Bio-imaging, By End User
    • Market Bio-imaging, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Technological advancements in bio-imaging modalities
    • Restraints
  • High capital investment requirements
    • Opportunities
  • Hybrid imaging systems
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Bio-imaging Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Bio-imaging Market, By Imaging Modality, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Position Emission Tomography (PET)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • X-ray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Bio-imaging Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals & diagnostic centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Academic & research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Pharmaceutical & biotech companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Bio-imaging Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Company Profile
    • Bracco Imaging S.P.A
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Bayer HealthCare Pharmaceuticals
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Esaote S.p.A
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Digirad Corporation
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • FONAR Corporation
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GE Healthcare
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hologic Inc
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hitachi Medical Corporation
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Lantheus Medical Imaging, Inc.
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Covidien Pharmaceuticals
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Mindray Medical International Limited.
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Gamma Medica Inc
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Samsung Medison Co., Ltd.
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Philips Healthcare
  • Company Highlights
  • Imaging Modality Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!